← FDA DRUG APPROVALS

FDA ANDA · ANDA203047

VALACYCLOVIR

Sponsor: HETERO LABS LTD V

APPLICATION
ANDA203047
TYPE
ANDA
ORIGINAL APPROVAL
2015-04-08
LATEST ACTION
2026-06-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

VALACYCLOVIR HYDROCHLORIDEPrescription
VALACYCLOVIR HYDROCHLORIDE EQ 500MG BASE · TABLET · ORAL
VALACYCLOVIR HYDROCHLORIDEPrescription
VALACYCLOVIR HYDROCHLORIDE EQ 1GM BASE · TABLET · ORAL

Approval history

2026-06-10Labeling · Supplement 20 · standardAP
2023-02-23Labeling · Supplement 14 · standardAP
2023-02-23Labeling · Supplement 12 · standardAP
2015-10-26Labeling · Supplement 1 · standardAP
2015-04-08UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →